Page last updated: 2024-09-05

gm237354 and Moniliasis, Oral

gm237354 has been researched along with Moniliasis, Oral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gargallo-Viola, D; Jimenez, E; Martinez, A; Regadera, J; Santos, I	1

Other Studies

1 other study(ies) available for gm237354 and Moniliasis, Oral

Article	Year
Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4 Topics: Animals; Anti-Inflammatory Agents; Antifungal Agents; Candida albicans; Candidiasis, Oral; Dexamethasone; Disease Models, Animal; Epithelium; Immunocompromised Host; Indenes; Male; Rats; Rats, Sprague-Dawley; Tongue	2001

Article

Year

Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.

Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4

Topics: Animals; Anti-Inflammatory Agents; Antifungal Agents; Candida albicans; Candidiasis, Oral; Dexamethasone; Disease Models, Animal; Epithelium; Immunocompromised Host; Indenes; Male; Rats; Rats, Sprague-Dawley; Tongue

2001